Sunday, September 6, 2026
ExploreSearch
Via News
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· July 29, 2026

P&G Announces Fourth Quarter and Fiscal Year 2026 Results

View original at finance.yahoo.com
P&G Announces Fourth Quarter and Fiscal Year 2026 Results Q4 '26: Net Sales +2%; Organic Sales 0%; Diluted EPS -15%; Core EPS -3% FY '26: Net Sales +3%; Organic Sales +1%; Diluted EPS +2%; Core EPS +1% CINCINNATI, July 29, 2026--(BUSINESS WIRE)--The Procter & Gamble Company (NYSE:PG) reported fourth quarter and fiscal…
Opening lines of the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Fiscal 2026 was a year of foundation building while continuing to grow sales and profit and return high levels of cash to shareowners despite a very challenging geopolitical and economic environment; expects progress in fiscal 2027 by doubling down on strategy, prioritizing the consumer, and funding investments with a strong productivity program.

    60% confidence

Data points we hold from this source

Procter & Gamble · core eps6.89 USD
Procter & Gamble · adjusted free cash flow productivity100 percent
Procter & Gamble · organic sales growth0 percent
Procter & Gamble · operating cash flow19.6 USD
Procter & Gamble · net income16.1 USD
Procter & Gamble · eps6.62 USD
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Capital Surge Meets Investor Caution: Record Funding Rounds and Government Contracts Amid Valuation Skepticism
A single-week cluster of large AI/fintech funding rounds (Socure, Stability AI, Emerald AI, Generalist AI, Instinct, Gatik, Regent Craft) shows venture capital still pouring into AI infrastructure, identity, and autonomy plays, while Palantir's Army TITAN contract win coincided with a 6% stock drop — signaling that even flagship AI-defense revenue isn't immune to market reassessment of AI valuations. Efficiency-focused innovations like Multiverse Computing's model compression suggest the sector is also pivoting toward cost/inference economics as capital intensity draws scrutiny.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Morgan Stanley & Co. LLC
The same metric (eps) for the same entity (Morgan Stanley & Co. LLC) reported for the identical fiscal period (Q1 2026) and observation date (2026-03-31) has two conflicting values: 3.43 USD_per_share vs 3.08 USD. This is not a temporal change — both observations claim to measure the same point in time. The ~10% discrepancy (0.35 USD difference) is material for a financial metric.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,981
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,981 facts checked against source5,273 source documents archived
Query this data → isubstrate.com
P&G Announces Fourth Quarter and Fiscal Year 2026 Results — Source | Via News | Via News